BioSyent Income Statement

Health Care & Life Sciences » Pharmaceuticals | BioSyent Inc.

BioSyent Inc. | Income Statement

Fiscal year is January-December. All values CAD Thousands.

2013

2014

2015

2016

2017

2018

Sales/Revenue

7,799.40

12,211.10

15,388.20

17,922.30

20,762.80

21,527

Cost of Goods Sold (COGS) incl. D&A

1,679.10

2,680.20

3,333.90

3,942.50

4,977.60

5,138.20

Gross Income

6,120.30

9,530.90

12,054.30

13,979.80

15,785.10

16,388.90

SG&A Expense

3,697.50

5,575.10

6,739.40

8,212.20

9,190.50

9,639.20

EBIT

2,422.80

3,955.80

5,314.90

5,767.60

6,498.40

6,749.70

Unusual Expense

142.60

215.60

58.40

65.40

Non Operating Income/Expense

3.20

156.00

42.00

14.20

281.40

536.40

Pretax Income

2,452.80

4,326.70

5,166.00

5,869.90

6,850.20

7,546.80

Income Tax

524.80

1,172.70

1,401.10

1,560.40

1,643.90

1,841.40

Consolidated Net Income

1,928.00

3,154.10

3,764.90

4,309.50

5,206.30

5,705.40

Net Income

1,928.00

3,154.10

3,764.90

4,309.50

5,206.30

5,705.40

Net Income After Extraordinaries

1,928.00

3,154.10

3,764.90

4,309.50

5,206.30

5,705.40

Net Income Available to Common

1,928.00

3,154.10

3,764.90

4,309.50

5,206.30

5,705.40

EPS (Basic)

0.14

0.23

0.27

0.30

0.36

0.39

Basic Shares Outstanding

13,511.90

13,677.50

13,872.50

14,366.10

14,463.10

14,512

EPS (Diluted)

0.13

0.22

0.26

0.30

0.36

0.39

Diluted Shares Outstanding

14,399.70

14,364.40

14,437.70

14,505.00

14,594.90

14,535.20

EBITDA

2,457.60

4,001.40

5,376.30

5,914.30

6,688.00

6,935

Other Operating Expense

96.20

Non-Operating Interest Income

33.30

72.40

108.60

116.40

128.70

326.10

About BioSyent

View Profile

Address	170 Attwell Drive Toronto Ontario M9W 5Z5 Canada
Employees	-
Website	http://www.biosyent.com
Updated	07/08/2019
BioSyent, Inc. is a specialty pharmaceutical company, which engages in the development of pharmaceutical and healthcare products. Its products include FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Aguettant System, and Cysview. The company was founded on April 28, 1947 and is headquartered in Ontario, Canada.

BioSyent Inc. | Income Statement

About BioSyent

StatInvestor